Suchergebnisse - "Hagihara, Mao"

PubPharm (8)

1

Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci : A systematic review and meta-analysis

enthalten in: Heliyon | 2024

von Umemura, T. | Kato, H. | Asai, N. | +4

2

Effect of High Blood Glucose Level on the Antimicrobial Activity of Daptomycin against Staphylococcus aureus in Streptozotocin-Induced Diabetic Mice

enthalten in: Japanese journal of infectious diseases | 2020

von Kondo, T. | Hagihara, M. | Esaka, Y. | +4

3

Retrospective study on clinical efficacy and safety for daptomycin intermittent doses with or without loading dose in renal failure patients

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2020

von Kato, H. | Hagihara, M. | Shibata, Y. | +5

4

Feasibility of Trypsin Digestion as a Sample Preparation for Daptomycin Quantification in Murine Skeletal Muscles

enthalten in: Biological & pharmaceutical bulletin | 2019

von Sakai, Y. | Murakami, E. | Kato, H. | +6

5

Considerations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus Infection

enthalten in: Chemotherapy | 2018

von Kato, H. | Hagihara, M. | Murakami, E. | +6

6

Eosinophilic pneumonia caused by daptomycin : Six cases from two institutions and a review of the literature

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2017

von Hirai, J. | Hagihara, M. | Haranaga, S. | +7

7

Clinical effectiveness of daptomycin loading dose in patients infected with Gram-positive pathogens

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2017

von Kato, H. | Hagihara, M. | Nishiyama, N. | +4

8

In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure

enthalten in: Antimicrobial agents and chemotherapy | 2014

von Bhalodi, A. | Hagihara, M. | Nicolau, D. | +1

1
[1]